iShares U.S. Pharmaceuticals ETF (IHE)

  • Loading...
#15

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Typical

Fund Description

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

Fund Snapshot Updated 04.16.2014

Previous Close $122.91 Expense Ratio 0.48%
YTD Return 4.27% Avg. 30-Day Volume 48,978
1-Year Return 26.8% Market Cap Loading...
Bid $122.88 Shares Outstanding 5,150,000
Ask $122.91 Dividends $1.23
Top 10 Holdings
Johnson & Johnson (JNJ) 14.41%
Pfizer Inc (PFE) 11.33%
Merck & Co Inc New (MRK) 10.53%
Bristol Myers Squibb Co (BMY) 7.35%
Lilly Eli & Co (LLY) 6.92%
Allergan Inc (AGN) 6.06%
Actavis Plc (ACT) 5.00%
Forest Labs Inc (FRX) 4.26%
Zoetis Inc (ZTS) 3.87%
Mylan Inc (MYL) 3.82%
% of Total Holdings 73.50%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds